维普中文期刊产品整合服务
14篇 您的检索式:作者名="Dasaratha"
    题名 作者 年代 出处 被引量
1Audit committee characteristics and investment in internal auditing显示文摘Abhijit Barua Dasaratha V Rama Vineeta Sharma 2010Journal of Accounting and Public Policy2010,,5:1
2Preparation and characterization of injectable microspheres of contraceptive hormones显示文摘DASARATHA DHANARAJU M VEMA K JAYAKUMAR R 2003Int J Pharm2003,268,12:1
3Audit Fees after Remediation of Internal Control Weaknesses 显示文摘Munsif Vishal K Raghunandan Dasaratha V Rama Meghna Singhvi 2011Accounting Horizons2011,25,1:1
4Deter- minants of audit committee diligenee显示文摘K RAGHUNANDAN DASARATHA V RAMA 2007Accounting Hori- zons2007,,3:1
5Costs to comply with SOX section 404显示文摘Jagan Krishnan Dasaratha Rama Yinghong Zhang 0,,:1
6Audit Committee Composition and Interaction with internal Auditing:Canadian Evidence显示文摘D.Paul Scarbrough Dasaratha V Rama K.Raghunandan 0,,12:1
7Silver Nanoparticles as Real Topical Bullets for Wound Healing显示文摘Thirumurugan Gunasekaran Tadele Nigusse Magharla Dasaratha Dhanaraju 2012Journal of the American College of Clinical Wound Specialists2012,,4:1
8CFO Gender and Accruals Quality 显示文摘Barua Abhijit Lewis F Davidson Dasaratha V Rama Sheela Thiruvadi 2010Accounting Horizons2010,24,1:1
9SOX Section 404 Material Weakness Disclosures and Audit Fees显示文摘Raghunandan K Dasaratha V.Rama 0,,:1
10Internal control reports and financial reporting problems 显示文摘McMullen Dorothy A Kannan Raghunandan and Dasaratha V Rama 1996Accounting Horizons1996,10,4:1
11Shareholder Voting on Auditor Sdection,Audit Fees,and Audit Quality显示文摘Mai Dao K.Raghunandan Dasaratha V.Rama 0,,01:1
12Auditor decision-making in different litigation environments: The Private Securities Litigation Reform Act, audit reports and audit firm size显示文摘Marshall A. Geiger K. Raghunandan Dasaratha V. Rama 2006Journal of Accounting and Public Policy2006,,3:1
13Process Modeling Using Stacked Neural Networks显示文摘Dasaratha V S Richard C S Eric B B 1996AIChE Journal1996,42,9:1
14Predictors of acceptance and willingness to pay for the COVID-19 vaccine in the general public of India: A health belief model approach显示文摘Objective:To determine the predictors of acceptance and willingness to pay(WTP)for the COVID-19 vaccine among the Indian public and to provide insights for future demand forecasts and pricing considerations.Methods:A nationwide,web-based,self-administered,crosssectional survey was conducted from 5 to 20 October 2020.The health belief model(HBM)approach was used as a theoretical framework to assess the predictors of acceptance of and WTP for the COVID-19 vaccine.Results:Of 2480 respondents,2451 completed the online survey,yielding a response rate of 98.8%.Participants who participated in the survey had diverse demographics in terms of their location,educational level,occupation type,and family income.Among 2451 respondents,the majority(89.3%)intended to receive the COVID-19 vaccine.Respondents with high perceived benefits of COVID-19 vaccination,such as reduction in worry(OR 5.87;95%CI 4.39-7.96)and sickness(OR 4.31;95%CI 3.31-5.62),showed higher intention to receive the vaccine.However,respondents with a high perception of the side effects and barriers to vaccination(OR 0.36;95%CI 0.25-0.54)and vaccine shortage(OR 0.58;95%CI 0.41-0.81)showed lower intention to receive the vaccine.The majority(2162,88.21%)of respondents were willing to pay an amount of INR:500-1000 or USD:6.81-13.62 for a dose of COVID-19 vaccine,with a median(Q1,Q3)of INR:500(500,1000)or USD:6.81(6.81,13.62).The higher marginal WTP for the COVID-19 vaccine was influenced by advanced age,marital status,female sex,intermediate educational background,high family income,fair or poor perceived health status,and no affordable barriers.Conclusions:The majority of respondents intended to receive the COVID-19 vaccine.Healthcare interventions focusing on HBM constructs and demographic predictors associated with low intention to receive the vaccine can be effective in enhancing the coverage of the COVID-19 vaccine.The findings of this study provide guidance for the future price considerations of the COVID-19 vaccine.Narayana Goruntla Sai Harshavardhan Chintamani Bhanu P Samyuktha S Kasturi Vishwanathasetty Veerabhadrappa Pradeepkumar Bhupalam Jinka Dasaratha Ramaiah 2021Asian Pacific Journal of Tropical Medicine2021,14,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费